Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions

US12337013B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12337013-B2
Application numberUS-202418763332-A
CountryUS
Kind codeB2
Filing dateJul 3, 2024
Priority dateApr 14, 2021
Publication dateJun 24, 2025
Grant dateJun 24, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions for preventing or decreasing cryptosporidiosis in animals are disclosed herein. The compositions include sources of hydrogen peroxide and are fed to animals. The animals may be neonatal calves and the cryptosporidiosis may be caused by Cryptosporidium parvum . Methods of preventing or decreasing cryptosporidiosis in animals by feeding the hydrogen peroxide-generating compositions to the animals are also disclosed. Some disclosed methods reduce the number of Cryptosporidium oocysts shed by an infected animal or reduce the infectivity of Cryptosporidium oocysts shed by an infected animal. Some methods include feeding the hydrogen peroxide-generating compositions to animals ultimately afflicted with cryptosporidiosis, and the animals gain weight despite the infection.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of reducing the infectivity of Cryptosporidium oocysts excreted by an animal, the method comprising: providing a liquid animal feed with a source of hydrogen peroxide to an animal before or after infection with Cryptosporidium spp., wherein the source of hydrogen peroxide is selected from sodium percarbonate and glucose oxidase with dextrose, wherein the source of hydrogen peroxide is provided at about 0.07 wt % to about 3.00 wt % of the liquid animal feed on a dry basis, wherein an ability of at least a portion of the Cryptosporidium oocysts excreted by the animal to infect a second animal is reduced compared to Cryptosporidium oocysts excreted by an animal not provided the source of hydrogen peroxide. 2. The method of claim 1 , wherein the animal is selected from a calf, lamb, goat kid, piglet, and foal. 3. The method of claim 1 , wherein the source of hydrogen peroxide is sodium percarbonate, and the sodium percarbonate is provided at 750 mg/head/day to 3000 mg/head/day. 4. The method of claim 1 , wherein the source of hydrogen peroxide is glucose oxidase with dextrose, the glucose oxidase is provided at 140 mg/head/day to 250 mg/head/day when the glucose oxidase has a concentration of 10,000 U/g, and the dextrose is provided at 3.5 g/head/day to 10.0 g/head/day. 5. The method of claim 1 , wherein the liquid animal feed is water, whole milk, milk replacer, waste milk, or an electrolyte solution. 6. The method of claim 1 , wherein the source of hydrogen peroxide is encapsulated. 7. The method of claim 1 , wherein the animal is a calf and the Cryptosporidium spp. is C. parvum. 8. The method of claim 1 , wherein in response to ingesting the source of hydrogen peroxide, the animal sheds fewer oocysts compared to an animal not provided the source of hydrogen peroxide. 9. A method of reducing the infectivity of Cryptosporidium oocysts excreted by a population of animals, the method comprising: providing a liquid animal feed with source of hydrogen peroxide to at least one animal in the population of animals before or after infection with Cryptosporidium spp., wherein the source of hydrogen peroxide is selected from sodium percarbonate and glucose oxidase with dextrose, wherein the source of hydrogen peroxide is provided at about 0.07 wt % to about 3.00 wt % of the liquid animal feed on a dry basis, wherein an ability of at least a portion of the Cryptosporidium oocysts excreted by the at least one animal to infect other animals in the population of animals is reduced compared to Cryptosporidium oocysts excreted by an animal the population of animals not provided the source of hydrogen peroxide. 10. The method of claim 9 , wherein the animals in the population of animals are domestic livestock animals. 11. The method of claim 10 , wherein the domestic livestock animals are calves, lambs, goat kids, piglets, or foals. 12. The method of claim 9 , wherein the source of hydrogen peroxide is sodium percarbonate, and the sodium percarbonate is provided at 750 mg/head/day to 3000 mg/head/day. 13. The method of claim 9 , wherein the source of hydrogen peroxide is glucose oxidase with dextrose, the glucose oxidase is provided at 140 mg/head/day to 250 mg/head/day when the glucose oxidase has a concentration of 10,000 U/g, and the dextrose is provided at 3.5 g/head/day to 10.0 g/head/day. 14. The method of claim 9 , wherein the liquid animal feed is water, whole milk, milk replacer, waste milk, or an electrolyte solution. 15. The method of claim 9 , wherein the animals in the population of animals are calves and the Cryptosporidium spp. is C. parvum. 16. A method of reducing the infectivity of Cryptosporidium oocysts excreted by an animal, the method comprising: providing a source of hydrogen peroxide to an animal before or after infection with Cryptosporidium spp., wherein the source of hydrogen peroxide is selected from sodium percarbonate and glucose oxidase with dextrose, wherein the source of hydrogen peroxide is provided at about 750 mg/head/day to about 10.25 g/head/day, wherein an ability of at least a portion of the Cryptosporidium oocysts excreted by the animal to infect a second animal is reduced compared to Cryptosporidium oocysts excreted by an animal not provided the source of hydrogen peroxide. 17. The method of claim 16 , wherein the source of hydrogen peroxide is sodium percarbonate, and the sodium percarbonate is provided at 750 mg/head/day to 3000 mg/head/day. 18. The method of claim 16 , wherein the source of hydrogen peroxide is glucose oxidase with dextrose, the glucose oxidase is provided at 140 mg/head/day to 250 mg/head/day when the glucose oxidase has a concentration of 10,000 U/g, and the dextrose is provided at 3.5 g/head/day to 10.0 g/head/day. 19. The method of claim 16 , wherein the source of hydrogen peroxide is provided directly to the animal, or is provided to the animal after addition to a liquid animal feed or a dry feed. 20. The method of claim 16 , wherein the source of hydrogen peroxide is first provided within 12 to 24 hours of birth, and then provided twice per day for 10 days.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12337013B2 cover?
Compositions for preventing or decreasing cryptosporidiosis in animals are disclosed herein. The compositions include sources of hydrogen peroxide and are fed to animals. The animals may be neonatal calves and the cryptosporidiosis may be caused by Cryptosporidium parvum . Methods of preventing or decreasing cryptosporidiosis in animals by feeding the hydrogen peroxide-generating compositions …
Who is the assignee on this patent?
Purina Animal Nutrition Llc
What technology area does this patent fall under?
Primary CPC classification A61K31/7004. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).